 |
| |
|
 |
 |
 |
Gonzalez Galdeano cleared to race on Posted: Wednesday July 17, 2002 5:37 AMUpdated: Wednesday July 17, 2002 7:51 AM BAZAS, France (Reuters) -- All the doping tests carried out on riders in this year's Tour de France up until July 12 have proved negative, the International Cycling Union (UCI) stressed Wednesday. The statement from cycling's governing body was issued after Wednesday's sports daily L'Equipe reported traces of the drug salbutamol had been found in a sample taken from Tour leader Igor Gonzalez Galdeano on July 12th. "Traces of salbutamol were found in a July 12 test" at the end of the stage from Forges-les-Eaux to Alencon, Tour spokesman Philippe Sudres earlier told The Associated Press. The UCI said some riders were allowed to use the drug to counter asthma. "The riders who tested over the limit for salbutamol had a prescription," the UCI said in a statement without naming the Spanish rider. "All the doping tests carried out since the start of the Tour de France until July 12th were negative," it continued. Gonzalez de Galdeano refused to comment as he was leaving his hotel to be driven to the starting line of Wednesday's 10th stage from Bazas to Pau in the south-west of France. "This is a non-story and I don't see what I could tell you
about a business which doesn't exist," Once team chief Manolo
Saiz said.
The Associated Press contributed to this report. |
|
|||||||||||||||||
|
|||||||||||||||||||
